Disagree - it is majorly a low ball offer when considering it is a long term view of the price being significantly more as I believe the tech is disruptive, once in a generation, that will change the way health is delivered - amd as Tony said himself - worth a lot more.
Ann: Second Supplementary Scheme Booklet, page-107
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
